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Background: Bileaﬂet mitral valve prolapse (biMVP) is associated with frequent ventricular ectopy (VE)
and malignant ventricular arrhythmia. We examined the effect of mitral valve (MV) surgery on VE
burden in biMVP patients.
Methods: We included 32 consecutive patients undergoing MV surgery for mitral regurgitation sec-
ondary to biMVP between 1993 and 2012 at Mayo Clinic who had available pre- and post-operative
Holter monitoring data. Characteristics of patients with a signiﬁcant reduction in postoperative VE
(group A, deﬁned as >10% reduction in VE burden compared to baseline) were compared with the rest of
study patients (group B).
Results: In the overall cohort, VE burden was unchanged after the surgery (41 interquartile range [16,
196] pre-surgery vs. 40 interquartile range [5186] beats/hour [bph] post-surgery; P ¼ 0.34). However, in
17 patients (53.1%), VE burden decreased by at least 10% after the surgery. These patients (group A) were
younger than the group B (59 ± 15 vs. 68 ± 7 years; P ¼ 0.04). Other characteristics including pre- and
postoperative left ventricular function and size were similar in both groups. Age <60 years was asso-
ciated with a reduction in postoperative VE (odds ratio 5.8; 95% conﬁdence interval, 1.1e44.7; P ¼ 0.03).
Furthermore, there was a graded relationship between age and odds of VE reduction with surgery (odds
ratio 1.9; 95% conﬁdence interval 1.04e4.3 per 10-year; P ¼ 0.04).
Conclusions: MV surgery does not uniformly reduce VE burden in patients with biMVP. However, those
patients who do have a reduction in VE burden are younger, perhaps suggesting that early surgical
intervention could modify the underlying electrophysiologic substrate.
Copyright © 2016, Indian Heart Rhythm Society. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Two recent studies have implicated that mitral valve prolapseNoseworthy).
Rhythm Society.
ociety. Production and hosting by
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ysiology Journal (2016), http:(MVP), particularly bileaﬂet prolapse, as a cause of sudden cardiac
death (SCD) in the setting of an otherwise structurally normal heart
[1,2]. Basso et al. found that 7% of young SCD victims had MVP as
the only identiﬁable abnormality on careful clinical evaluation and
autopsy [1]. Further, Sriram and colleagues described a novel syn-
drome marked by the tetrad of bileaﬂet MVP, frequent ventricular
ectopy (VE), female preponderance, and repolarization abnormal-
ities within a cohort of survivors after unexplained out-of-hospitalElsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
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Although implantable cardioverter deﬁbrillator (ICD) therapy
could reduce the risk of SCD in some high risk patients, there are no
known therapies to reduce the burden of ventricular ectopy or risk
of sustained ventricular arrhythmia. In isolated case reports, mitral
valve surgery has been shown to reduce the burden of refractory
ventricular arrhythmia [3e5]; however, not all MVP patients have a
uniform reduction in arrhythmia burden after the surgery [6].
Moreover, MV surgery could potentially be pro-arrhythmic in some
patients. To clarify the relationship between mitral valve surgery
and VE burden, we sought to 1) determine whether MV surgery
alters the burden of VE in bileaﬂet MVP patients, and 2) identify
factors associated with a reduction in postoperative VE burden.
2. Materials and methods
This studywas approved by theMayo Clinic Institutional Review
Board waiving the informed consent. The study utilized data from
the Mayo Clinic Surgical Database including consecutive patients
who had undergone MV surgery at Mayo Clinic d Rochester from
October 1, 2007 through February 28, 2013. Eligibility criteria were
as follows:
1) Patients underwent MV surgery primarily due to bileaﬂet MVP.
2) Patients had MV surgery after October 1, 2007 when the Holter
database at our institution became available electronically.
3) Patients had both pre- and post-operative Holter monitor data
for review.
4) Patients were 18 years at the time of surgery.
Patients without research authorization were excluded. The
ﬁnal cohort comprised 32 consecutive bileaﬂet MVP patients who
had undergone MV surgery at the Mayo Clinic d Rochester with
available pre- and post-operative Holter monitors.Fig. 1. Electrocardiographic tracings identify site of origin of ventricular ectopy. (A) demonstr
atypical right bundle branch block morphology (V1 lead) and inferior right axis. (B) prese
bundle branch block morphology but superior and left axis. (C) Right ventricular outﬂow tr
deﬂection in leads II, III, and aVF. In contrast to ectopy from left ventricular outﬂow tract,
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Medical records were reviewed to deﬁne the clinical, echocar-
diographic, and surgical data. All study patients underwent surgery
for symptomatic severe mitral regurgitation secondary to bileaﬂet
MVP conﬁrmed by preoperative echocardiographic imaging and at
surgical inspection [7]. Patients with ICDs were identiﬁed through a
review of ICD interrogation reports for anti-tachycardia therapies
or ICD shock. Follow-up was until February 30, 2014.
2.2. Holter monitoring data
Holter monitors were not routinely preformed in patients un-
dergoing MV surgery at our institution and those without pre- and
post-operative Holter monitors were excluded. In this study cohort,
the indications for Holter monitors were palpitations (53.1%), atrial
ﬁbrillation (21.9%), known premature ventricular contraction
(PVC)/non-sustained ventricular tachycardia (NSVT) (9.3%), syn-
cope (3.1%), VT (3.1%), dyspnea (3.1%) and dizziness (3.1%), respec-
tively. The Holter monitors data were reviewed for VE frequency, or
number of ectopic, beats/hour (bph) in a 24-h period. The
morphology data of pre- and post-operative VE was gathered from
Holter monitors and 12-lead electrocardiographic tracings when
available. The site of origin was grouped into outﬂow tract
including right ventricular outﬂow tract (RVOT), left ventricular
outﬂow tract (LVOT), papillary muscles (anterolateral or poster-
omedial muscles), or other, according to published criteria by two
observers (FFS and EE) [8e10] (See Fig. 1). Discrepancies were
resolved by consensus. Abnormalities in the T-wave morphology,
i.e. ﬂattening or inversion, were noted.
The formula for percent changes in postoperative VE burdenwas
as follows: (Postoperative VE frequency/Preoperative VE frequency
- 1) x 100. More than 10% reduction in VE frequency was deﬁned as
a signiﬁcant reduction.ates ventricular ectopy from anterolateral papillary muscle with wide QRS complex and
nts posteromedial papillary muscle ventricular tachycardia with similar atypical right
act ectopy with negative in V1 lead (left bundle branch bock morphology) and positive
(D) which has positive reﬂection in V1 lead.
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Variables are presented asmean ± standard deviation ormedian
and interquartile range (IQR). Patients were categorized by a sig-
niﬁcant reduction in postoperative VE (group A) and the rest (group
B). Their baseline characteristics were compared using a t-test for
continuous variables with normal distribution or a non-parametric
Wilcoxon rank-sum test for continuous variables with skewed
distribution, and a chi-square test or Fisher's exact test for cate-
gorical variables.
A univariate analysis was performed to evaluate the association
between clinical and echocardiographic characteristics and the
changes in VE frequency postoperatively. The odds ratio (OR) with a
95% conﬁdence interval (CI) were reported. All comparisons were
two-sided, and a P value < 0.05 was considered statistically sig-
niﬁcant. Statistical analyses were performed using JMP statistical
software version 9.0 (SAS Institute, Inc., Cary, NC) and MedCalc
version 12.5 (MedCalc Software, Ostend, Belgium).
3. Results
3.1. Study patients
Patients were 63.5 ± 12.8 years and 53.1% were female. All pa-
tients had severe mitral regurgitation primarily due to bileaﬂet
MVP. Ninety four percent of patients underwent MV repair and
18.8% had concomitant coronary artery bypass graft surgery
(CABG). No patients had more than mild MR during 6.3 ± 5.3years
of follow-up after the surgery. Time of preoperative Holter moni-
toring to the surgery and time of surgery to postoperative Holter
monitoring were 288 ± 330 days (98 IQR [39, 557] days) and
251 ± 387 days (102 IQR [47, 213] days), respectively.
Overall, the VE frequency was unchanged after the surgery (41
IQR [16, 196] vs. 40 IQR [5, 186] beats per hour [bph]; P ¼ 0.34). The
origins of preoperative VE were papillary muscles (28.6%) and
outﬂow tracts (14.3%), in comparison to the origins of postoperative
VE which were papillary muscles (48.3%) and outﬂow tractsTable 1
Clinical characteristics of study patients with and without a signiﬁcant reduction in ven
All patients
Age, years, (mean ± SD) 63.5 ± 12.8
Female, No. (%) 17 (53.1)
Pre-operative NYHA class III/IV, No. (%) 9 (28.1)
Pre-operative reported palpitations, No. (%) 19 (59.4)
Pre-operative antiarrhythmic drugsa, No. (%) 18 (56.3)
Post-operative antiarrhythmic drugsb, No. (%) 21 (65.6)
Pre-operative atrial ﬁbrillation, No. (%) 14 (43.8)
Pre-operative T-wave abnormalities, No. (%) 10 (31.4)
Mitral Valve appearance
Flail, No. (%) 8 (25.0)
Myxomatous, No. (%) 13 (40.6)
Surgery
Mitral valve repair, No. (%) 30 (93.8)
Papillary muscle manipulation, No. (%) 11 (34.38)
CABG, No. (%) 6 (18.8)
Preoperative Holter
Time of Holter monitors to time of surgery, days, median [IQR] 98 [39, 557
Preoperative VE frequency, bph, median [IQR] 41 [16, 196
Postoperative Holter
Time of surgery to time of Holter monitors, days, median [IQR] 102 [47, 21
Postoperative VE frequency, bph, median [IQR] 40 [5, 186]
Percent change, %, median [IQR] 13 [-77, 5
Absolute changes in VE frequency, bph, median [IQR] 3 [-104, 2
Abbreviations: bph, beats per hour; CABG, Coronary Artery Bypass Graft Surgery; IQR, In
Ventricular Ectopy.
a Beta blocker, calcium channel blocker, ﬂecainide, digoxin, sotalol.
b Beta blocker, calcium channel blocker, digoxin, sotalol.
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operative VE were present in 21.4% and 55.2%, respectively
(P ¼ 0.47).
3.2. Patients with and without signiﬁcant reduction in ventricular
ectopy
There were 17 patients (53.1%) who met the criteria for a sig-
niﬁcant reduction in postoperative VE frequency (group A). In this
group, their postoperative VE frequency had decreased from 102
IQR [31, 430] to 34 IQR [3, 197] bph; P < 0.0001, when compared to
the group B who had an increase in postoperative VE (30 IQR [5,
130] vs. 183 IQR [8, 270] bph, respectively; P ¼ 0.02). Patients in the
group A were younger (59.3 ± 15.2 vs. 68.2 ± 7.2 years; P ¼ 0.04)
than the group B. Other clinical characteristics including gender,
New York Heart Association Functional Classiﬁcation, prevalence of
preoperative atrial ﬁbrillation, concomitant CABG and antiar-
rhythmic drugs administration were similar in both groups
(P > 0.05 for all comparisons, shown in Table 1). Further, the groups
are similar with respect to pre- and post-operative left ventricular
ejection fraction and dimension (Table 2).
Both groups had comparable origin of VE during preoperative
(P ¼ 0.89) and postoperative periods (P ¼ 0.82). In groups A and B,
preoperative VE was originated from papillary muscles (25.0% and
16.7%, respectively), outﬂow tracts (12.3% and 33.3%, respectively)
and multifocal sites (25.0% and 16.7%, respectively). As for post-
operative VE, there were 43.8% and 53.8% of papillary muscles,
25.0% and of 30.8% of outﬂow tracts, as well as 25% and 61.5% of
multifocal VE in the group A and B, respectively.
3.3. Age as a predictor of reduction in ventricular ectopy frequency
Different age cutoffs altered the prevalence of signiﬁcant
reduction in VE frequency after the surgery. Each 10 year decrease
in age was associated with a possibility of reduction in VE fre-
quency by 1.9 (95% CI 1.04e4.3; P ¼ 0.04).
All of the patients who underwent MV surgery at age <55 yearstricular ectopy after mitral valve surgery.
(N ¼ 32) Group A (N ¼ 17) Group B (N ¼ 15) P value
59.3 ± 15.2 68.2 ± 7.2 0.04
7 (41.2) 10 (66.7) 0.15
5 (29.4) 4 (26.7) 1.00
9 (52.9) 10 (66.7) 0.43
10 (58.8) 8 (53.3) 0.75
11 (64.7) 10 (66.7) 0.91
6 (35.3) 8 (53.3) 0.30
6 (35.3) 4 (26.7) 0.39
4 (23.5) 4 (26.7) 1.00
9 (52.9) 4 (26.7) 0.17
16 (94.1) 14 (93.3) 1.00
5 (29.4) 6 (40.0) 0.53
3 (17.7) 3 (20.0) 0.86
] 98 [27, 394] 126 [43, 712] 0.41
] 102 [31, 430] 30 [5, 130] 0.05
3] 68 [33, 215] 170 [85, 217] 0.67
34 [3, 197] 183 [8, 270] 0.12
4] 76 [-91, 40] 57 [42, 538] 0.03
3] 99 [-290, 12] 28 [5, 158] 0.01
terquartile Range; NYHA, New York Heart Association; SD, Standard Deviation; VE,
ve surgery on ventricular arrhythmia in patients with bileaﬂet mitral
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Table 2
Echocardiographic parameters of study patients with and without a signiﬁcant reduction in ventricular ectopy after mitral valve surgery.
All patients (N ¼ 32) Group A
(N ¼ 17)
Group B
(N ¼ 15)
P value
Preoperative echocardiographic parameters
LVEF, %, (mean ± SD) 63.2 ± 5.6 63.4 ± 4.0 62.9 ± 7.2 0.80
LVESD, millimeters, (mean ± SD) 36.5 ± 5.9 36.5 ± 5.0 36.0 ± 7.0 0.81
LVEDD, millimeters, (mean ± SD) 56.6 ± 7.3 56.2 ± 6.4 56.9 ± 8.5 0.80
Postoperative echocardiographic parameters
LVEF, %, (mean ± SD) 53.4 ± 11.7 54.9 ± 10.1 51.6 ± 13.4 0.44
LVESD, millimeters, (mean ± SD) 35.5 ± 8.1 35.3 ± 6.6 35.8 ± 9.8 0.87
LVEDD, millimeters, (mean ± SD) 50.6 ± 6.5 50.6 ± 6.5 50.5 ± 6.8 0.94
Abbreviations LV Left Ventricular; LVEDD, Left Ventricular End Diastolic Dimension; LVEF, Left Ventricular Ejection Fraction; LVESD, Left Ventricular End Systolic Dimension;
SD, Standard Deviation.
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contrast, patients who underwent MV surgery at age <65 years and
<70 years had a possibility of signiﬁcant reduction in VE frequency
66.7%% and 59.1%, respectively. At age <60 years, the prevalence of
signiﬁcant reduction in VE frequency was 80.0%, with OR 5.8; 95%
CI, 1.1e44.7; P ¼ 0.03.
3.4. Patients with sustained ventricular arrhythmias
Of the entire cohort, there was one patient (3.1%) who had
sustained ventricular arrhythmias and received appropriate ICD
shocks prior to the surgery. The patient was a 38-year-old manwho
presented with syncope and inducible ventricular ﬁbrillation at an
outside facility. Echocardiography identiﬁed bileaﬂet MVP without
other structural heart disease at the time of sustained ventricular
tachycardia (VT). Subsequently, he had several appropriate ICD
shocks for VT originating from the papillary muscle. Ten years after
the initial presentation, at age of 48 years, the patient underwent
MV repair for newly developed severe mitral regurgitation sec-
ondary to MVP. His pre- and postoperative VE frequency was 69
and 57 bph, respectively, with a percent reduction of 18%. At one-
year follow-up after the surgery, ICD interrogation showed no ev-
idences of recurrent ventricular arrhythmias.
4. Discussion
The main ﬁndings of this study are as follows: 1) Mitral valve
surgery does not uniformly reduce VE frequency in patients with
bileaﬂet MVP; 2) Patients who garner at least a 10% reduction in
overall VE burden tend to be younger than those who do not. The
idea that early surgical intervention may be associated with a
reduction in electrophysiologic manifestations of bileaﬂet MVP is
further supported by a graded relationship between age and odds
of a reduction in postoperative VE frequency.
Current data on the effect of the mitral valve surgery on VA in
the context of MVP are mixed and mostly derive from small single
center studies. Vohra et al., described two MVP patients (ages 62
and 63 years), who underwent MV surgery in an effort to control
ventricular tachycardia but continued to have inducible mono-
morphic VT after the surgery [6]. In contrast, other case series have
reported successful VA reduction with surgical intervention [3e5].
It is noteworthy that these published cases of successful reduction
in VE with surgery tended to be in younger patients (mean age 42.6
years), compared to those with refractory arrhythmias (mean age
62.5 years). The current study, therefore, conﬁrms the results of
prior observation that age is a potential predictor of a signiﬁcant
reduction in VE frequency after mitral valve surgery.
It has been hypothesized that a mechanical triggering source
from the redundant mitral apparatus may set off VA [2,11e14]. InPlease cite this article in press as: Naksuk N, et al., The effect of mitral val
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have a signiﬁcant reduction in VE frequency suggests that the
mechanical trauma is not the sole etiology, but a progressive
arrhythmic substrate may form over time in the setting of long-
standing MVP. Therefore, mitral valve repair or replacement could
not reduce VE burden in the older patients. Our hypothesis is
supported by evidence from recent studies involving cardiac
magnetic resonance (CMR) among MVP patients. Han et al. and
Basso et al. demonstrated the presence of late gadolinium
enhancement (LGE) at the tip of the papillary muscle adjacent to
the attachment of chordae tendineae and mitral annulus, as well as
the mid-apical portion and the infero-basal left ventricular wall at
the papillary muscle level, respectively, in MVP patients with
complex ventricular arrhythmias, when compared with no evi-
dence of LGE in MVP patients without history of PVC [1,12]. From
the histology perspective, Basso et al. has recently demonstrated
signiﬁcant ﬁbrosis at the regions similar to the results from CMR
studies [1]. These ﬁndings and our results, therefore, provide
convincing evidence that the developing of substrate formation is
likely a mechanistic underlying of arrhythmias in MVP.
Collective data from electrocardiograms and electrophysiology
studies also demonstrate that frequent PVCs in MVP patients
mostly originated from the structure close to the prolapsing leaﬂet
which is consistent with scar formation previously mentioned
[1,2,15]. Of all locations, the papillary muscles appear to be a
prominent origin of PVCs. Ablation of papillary arrythmias in MVP
patients with refractory VT was reportedly sucessful [16,17].
In this study, however, the proportion of VE arising from
papillary muscles was generally increased after the surgery, irre-
spective of reduction in total VE frequency. There are few expla-
nations for this observation. First, different surgical technique
might have resulted in manipulation of papillary muscles and
subsequent papillary VE. Secondly, it may be simply because of the
challenge in distinguishing arrhythmias arising from papillary
muscles and other adjacent structures (i.e., fascicles and mitral
annulus) by a standard electrocardiogram, especially in the pres-
ence of infrequent PVCs [18].
This study observed generally low preoperative VE frequency
(41 bph) among patients with bileaﬂet MVP. Although the tradi-
tional cutoff of >10,000 beats per 24 h suggestive of signiﬁcant VE
burden, Sriram et al. reported a malignant bileaﬂet MVP syndrome
associated with baseline VE frequency of only 67 bph [2]. In addi-
tion, we observed sustained ventricular tachycardia in a 38-year old
man with relatively low baseline VE frequency. Therefore, it is
plausible that risk of malignant VAs in MVP patients may depend
on collective several predictive features and not exclusively
depended on VE frequency [2,6,19e21]. On the other hand, we
cannot translate that reduction in VE frequency by mitral valve
surgery would equally eliminate the risk of SCD.ve surgery on ventricular arrhythmia in patients with bileaﬂet mitral
//dx.doi.org/10.1016/j.ipej.2016.10.009
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Other limitations of this study merit comments. Our study
which was conducted in a tertiary medical center is limited by its
retrospective design and potential referral bias. Despite its use of a
largest MVP cohort with available perioperative Holter monitors,
sample size of the study was small. As a result, we were not able to
perform multivariate analysis to determine an independent asso-
ciation between age and postoperative VE frequency. Since routine
Holter monitors were not performed during pre- and post-surgery,
we may have excluded signiﬁcant numbers of patients who were
asymptomatic but had signiﬁcant VE burden. Finally, this cohort
included leaﬂet MVP patients with signiﬁcant MR, thus the sole
effect of surgery on VE burdenmay not be clearly stated. To test the
clinical implication of our ﬁndings, larger cohorts of MVP patients
in the absence of hemodynamically complicated mitral regurgita-
tion are warranted.
5. Conclusions
This retrospective study demonstrates that mitral valve surgery
does not uniformly reduce the burden of ventricular arrhythmias in
patients with bileaﬂet MVP. Younger patients, however, are more
likely to garner a beneﬁt in terms of arrhythmia reduction. These
observations may suggest that early surgical intervention arrests
progressive arrhythmogenic substrate formation.
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